Inhibikase Therapeutics
IKT
IKT
21 hedge funds and large institutions have $7.78M invested in Inhibikase Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
27% less capital invested
Capital invested by funds: $10.6M → $7.78M (-$2.84M)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$257K | |
| 2 | +$192K | |
| 3 | +$101K | |
| 4 |
Bank of New York Mellon
New York
|
+$75K |
| 5 |
BlackRock
New York
|
+$70.3K |